Breakthrough Pain - 25 Studies Found Terminated : Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain : Pain Chronic Pain Breakthrough Pain< : 2006-10-10 : Drug: Fentanyl Buccal Tablets Fentanyl buccal tablets (FBT Completed : Quality of Life Study in Patients With Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent : Breakthrough Pain : 2016-07-11 : Other: No intervention No intervention Completed : Staccato Fentanyl Single and Multidose PK : Breakthrough Pain : 2006-11-20 : Drug: Inhaled Placebo Inhaled Completed : Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM) : Cancer Pain : 2006-06-26 : Drug: Fentanyl Completed : Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects : Pain Cancer : 2006-02-15 : Drug: BEMA™ Fentanyl Completed : Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy : Pain Cancer : 2006-02-15 : Drug: BEMA Fentanyl buccal soluble film; 200, 400, 600, 800, 1200 mcg fentanyl; up to 4 times daily Completed : A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain : Cancer Pain : 2009-01-28 : Drug: Sublingual sufentanil NanoTabs™ and placebo NanoTabs™ During the Titration Phase, pati Completed : Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM) : Pain : 2007-07-03 : Drug: Nasal fentanyl Breakthrough pain in patients with breast or prostate cancer Completed : Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM) : Cancer : 2006-08-09 : Drug: Fentanyl Completed : Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients : Pain Cancer : 2005-03-11 : Drug: OraVescent fentanyl (OVF) <<< Previous | Next >>>
